Cargando…

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma

Accumulating evidence has shown that PD-L1 expression is associated with clinicopathological features in various human malignancies. We searched for correlations between PD-L1 expression and clinicopathological data in esophageal squamous cell carcinoma (ESCC) patients. PD-L1 expression in primary t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Dongxian, Song, Qi, Wang, Haixing, Huang, Jie, Wang, Hao, Hou, Jun, Li, Xiaojing, Xu, Yifan, Sujie, Akesu, Zeng, Haiying, Tan, Lijie, Hou, Yingyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352403/ https://www.ncbi.nlm.nih.gov/pubmed/28039448 http://dx.doi.org/10.18632/oncotarget.14174

Ejemplares similares

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2017)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017)

Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification
por: Jiang, Dongxian, et al.
Publicado: (2020)

Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery
por: Wang, Xingxing, et al.
Publicado: (2021)

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2022)

Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy
por: Jiang, Dongxian, et al.
Publicado: (2023)

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma
por: Xu, Chen, et al.
Publicado: (2017)

Chromosomal and Genomic Variations in Esophageal Squamous Cell Carcinoma: A Review of Technologies, Applications, and Prospections
por: Song, Qi, et al.
Publicado: (2017)

SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2021)

Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
por: Wang, Yanqiu, et al.
Publicado: (2019)

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome
por: Huang, Jie, et al.
Publicado: (2021)

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
por: Song, Qi, et al.
Publicado: (2021)

Identification of clinical prognostic features of esophageal cancer based on m6A regulators
por: Wang, Huimei, et al.
Publicado: (2022)

Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients
por: Ming, Zizhen, et al.
Publicado: (2014)

Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis
por: Guo, Wei, et al.
Publicado: (2017)

The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China
por: Xue, Xuemin, et al.
Publicado: (2022)

Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma
por: Yang, Yu-Shang, et al.
Publicado: (2017)

Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
por: Wang, Yunzhi, et al.
Publicado: (2023)

An alternative high output tissue microarray technique
por: Shi, Yuan, et al.
Publicado: (2013)

HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma
por: Chen, Lingli, et al.
Publicado: (2022)

Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma
por: Jiang, Yubo, et al.
Publicado: (2017)

Integrative proteogenomic characterization of early esophageal cancer
por: Li, Lingling, et al.
Publicado: (2023)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
por: Xu, Chen, et al.
Publicado: (2017)

Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment
por: Chen, Weijie, et al.
Publicado: (2021)

The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer
por: Pan, Weiyu, et al.
Publicado: (2020)

Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma
por: Wang, Zhen, et al.
Publicado: (2018)

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
por: Li, Yan, et al.
Publicado: (2022)

Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
por: Li, Yan, et al.
Publicado: (2022)

Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma
por: Wang, Qifeng, et al.
Publicado: (2013)

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021)

Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Zhao, Songchen, et al.
Publicado: (2023)

Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma
por: Huang, Xiancong, et al.
Publicado: (2023)

Prognostic Significance of Serum PD-L1 Level in Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Combination Cytotoxic Chemotherapy
por: Fu, Rong, et al.
Publicado: (2021)

Relationship between PD-L1 expression and molecular aberrances in lung adenocarcinoma with solid components
por: Zhu, Kun, et al.
Publicado: (2023)

PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
por: Wang, Qiao, et al.
Publicado: (2018)

The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
por: Lin, Dong, et al.
Publicado: (2021)

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
por: Zhang, Aijia, et al.
Publicado: (2019)

Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma
por: Shi, Xuejiao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jatjq8f3jb6jm2rcv2rm3efpe3